Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.96% | 85.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.96% | 85.36% | |||
| Cost of Revenue | 7.24% | 50.59% | |||
| Gross Profit | 17.72% | 94.40% | |||
| SG&A Expenses | 16.37% | 14.01% | |||
| Depreciation & Amortization | 7.43% | 25.94% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.42% | 27.21% | |||
| Operating Income | 19.79% | 4.46% | |||
| Income Before Tax | 50.42% | 11.33% | |||
| Income Tax Expenses | -5.54% | 17.50% | |||
| Earnings from Continuing Operations | 50.21% | 11.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.21% | 11.23% | |||
| EBIT | 19.79% | 4.46% | |||
| EBITDA | 19.98% | 5.12% | |||
| EPS Basic | 50.63% | 12.01% | |||
| Normalized Basic EPS | 19.31% | 3.57% | |||
| EPS Diluted | 50.59% | 12.11% | |||
| Normalized Diluted EPS | 19.31% | 3.57% | |||
| Average Basic Shares Outstanding | 0.86% | 0.89% | |||
| Average Diluted Shares Outstanding | 0.86% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||